CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Dec. 31, 2012
Cash flows from operating activities
Net loss	$ (4,078,366)	$ (1,550,312)	$ (5,574,775)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts	(31,528)	10,521
Depreciation and amortization	35,846	111,851
Stock-based compensation	330,021	259,409
Warrants issued to 2012 private placement investors	487,200
Loss on extinguishment of notes and accounts payable	2,792,900
Imputed value of services contributed	87,500
Amortization of debt discount	44,363	215,711
Changes in operating assets and liabilities:
Accounts receivable	(6,238)	21,542
Inventories - finished goods	85,519	106,206
Prepaid expenses and other current assets	10,451	17,386
Accounts payable - trade	(91,216)	550,400
Accounts payable - related parties	185,999	(4,902)
Accrued expenses and other current liabilities	(340,265)	84,793
Deferred revenue	30,441
Net cash used in operating activities	(457,373)	(177,395)	(947,911)
Cash flows from investing activities
Change in restricted cash	725,002
Changes in employee advances		(81,043)
Website development costs	(25,490)
Net cash provided by (used in) investing activities	699,512	(81,043)
Cash flows from financing activities
Principal payments on equipment leases payable	(11,759)	(22,131)
Proceeds from issuance of notes payable	500,000
Repayment of notes payable	(2,000,000)
Repayment of convertible notes payable	(1,000,000)
Proceeds from the sale of common stock	2,526,973	125,000
Proceeds from offering in advance of equity offering closing	125,000
Cash overdraft		(155,656)
Proceeds from notes payable and other advances - related parties		375,000
Repayment of notes payable and other advances - related parties		(63,812)
Net cash provided by financing activities	140,214	258,401
Net increase (decrease) in cash	382,353	(37)
Cash - beginning of year		40	40
Cash - end of year	382,353	3
Interest	367,978	21,491
Taxes
Non-cash investing and financing activities:
Issuance of Series B preferred stock for settlement of accrued dividends	261,084	244,001
Cashless exercise of warrants into common stock	6,934
Cashless exercise of options into common stock		93
Warrants issued as debt discount in connection with notes payable	315,300
Accrual of contractual dividends on Series B convertible preferred stock	69,840	65,271
Deemed dividends on Series B convertible preferred stock	1,532,722
Reclassification of accounts payable - trade to equipment lease payable		257,583
Deemed dividend - redeemable Series C preferred stock		92,916
Common stock and warrants issued in exchange of notes and accounts payable	$ 3,625,900